arrow
A

Andrew C. Peet

Birmingham Children's Hospital
H指数:40
被引数:7,019

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation

人工智能在儿科神经肿瘤学反应评估中的应用(AI-RAPNO),第二部分:临床转化中的挑战、机遇与建议

2025-10-270
PRE
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the art

人工智能在儿科神经肿瘤学反应评估中的应用(AI-RAPNO),第一部分:当前技术状态的综述

2025-10-270
PRE
MONOGERM, A NOVEL PROOF-OF-PRINCIPLE BAYESIAN PHASE II TRIAL DESIGN OF CARBOPLATIN OR VINBLASTINE MONOTHERAPY INDUCTION PRIOR TO RADIOTHERAPY FOR INTRACRANIAL GERMINOMA
2024-11-110
PRE
MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma
2024-10-080
OAAI
MONOGERM, A NOVEL PROOF-OF-PRINCIPLE BAYESIAN PHASE II TRIAL DESIGN OF CARBOPLATIN OR VINBLASTINE MONOTHERAPY INDUCTION PRIOR TO RADIOTHERAPY FOR INTRACRANIAL GERMINOMA
2024-06-180
OAAI
Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups

髓母细胞瘤的代谢物谱,用于分子疾病组的快速和无创检测

2024-02-012
OAAI
Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging
2023-01-1113
OA
MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial

小儿高级别中线丘脑胶质瘤的MRI和分子表征: HERBY II期试验

RADIOLOGY
IF15.2
2022-07-0119
OA
Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation

肌醇治疗通过抑制表观遗传驱动的代谢适应来抑制髓母细胞瘤

2021-04-1221
OAAI
Molecular characterization of DICER1-mutated pituitary blastoma

DICER1-mutated垂体母细胞瘤的分子特征

2021-03-0118
PREAI
Classification of paediatric brain tumours by diffusion weighted imaging and machine learning
2021-02-0436
OAAI